ScoreWhy is Panacea Biotec Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -0.13% and Operating profit at -218.34% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -9.36
2
Negative results in Sep 25
- PBT LESS OI(Q) At Rs -28.27 cr has Fallen at -962.78%
- PAT(Q) At Rs -16.62 cr has Fallen at -907.2%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 81.61 cr
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -23.98%, its profits have fallen by -79.9%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -23.98% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Panacea Biotec for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Panacea Biotec
-23.78%
-0.46
51.41%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.13%
EBIT Growth (5y)
-218.34%
EBIT to Interest (avg)
-9.36
Debt to EBITDA (avg)
4.30
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.76
Tax Ratio
8.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.86%
ROCE (avg)
-10.90%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
2.54
EV to EBIT
-28.33
EV to EBITDA
-53.85
EV to Capital Employed
2.67
EV to Sales
3.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.42%
ROE (Latest)
-5.72%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-8What is not working for the Company
PBT LESS OI(Q)
At Rs -28.27 cr has Fallen at -962.78%
PAT(Q)
At Rs -16.62 cr has Fallen at -907.2%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 81.61 cr
EPS(Q)
Lowest at Rs -2.27
Loading Valuation Snapshot...
Here's what is not working for Panacea Biotec
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -28.27 cr has Fallen at -962.78%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -16.62 cr has Fallen at -907.2%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -2.27
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 81.61 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
